Press Releases

Search Press Releases
  
Subscribe for Email Alerts
5/23/2019
8:30 AM ET
Press Release

Mustang Bio and St. Jude Children’s Research Hospital to Participate in Panel Discussion at Boston CEO 2019

5/23/2019

NEW YORK, and MEMPHIS, Tenn., May 23, 2019 (GLOBE NEWSWIRE) -- Mustang Bio, Inc. (“Mustang”) (NASDAQ: MBIO), a clinical-stage biopharmaceutical company focused on translating today’s medical breakth...

 Continue Reading
5/16/2019
8:00 AM ET
Press Release

Mustang Bio and Nationwide Children’s Hospital Receive Orphan Drug Designation for MB-108 (Oncolytic Virus C134) for the Treatment of Malignant Glioma

5/16/2019

NEW YORK and COLUMBUS, Ohio, May 16, 2019 (GLOBE NEWSWIRE) -- Mustang Bio, Inc. (“Mustang”) (NASDAQ: MBIO), a clinical-stage biopharmaceutical company focused on translating today’s medical breakthr...

 Continue Reading
5/13/2019
8:00 AM ET
Press Release

Mustang Bio to Present at the Cell & Gene Therapy USA Congress 2019

5/13/2019

NEW YORK, May 13, 2019 (GLOBE NEWSWIRE) -- Mustang Bio, Inc. (“Mustang”) (NASDAQ: MBIO), a clinical-stage biopharmaceutical company focused on translating today’s medical breakthroughs in cell and g...

 Continue Reading
5/10/2019
7:30 AM ET
Earnings Release

Mustang Bio Reports First Quarter 2019 Financial Results and Recent Corporate Highlights

5/10/2019

NEW YORK, May 10, 2019 (GLOBE NEWSWIRE) -- Mustang Bio, Inc. (“Mustang”) (NASDAQ: MBIO), a clinical-stage biopharmaceutical company focused on translating today’s medical breakthroughs in cell and g...

 Continue Reading
5/8/2019
9:25 AM ET
Press Release

Mustang Bio Announces Full Exercise of Option

5/8/2019

NEW YORK, May 08, 2019 (GLOBE NEWSWIRE) -- Mustang Bio, Inc. (“Mustang”) (NASDAQ: MBIO), a clinical-stage biopharmaceutical company focused on translating today’s medical breakthroughs in cell and g...

 Continue Reading
Displaying 1 to 5 (of 62 releases)